Transition of Treatment Modalities for Peripheral Arterial Occlusive Disease for the Recent 5 Years According to the TASC II Classifications in a Single Institution.
- Author:
Won Pyo CHO
1
;
Hye Jung CHA
;
Eun Mi KONG
;
Yong Sun JEON
;
Soon Gu CHO
;
Jang Yong KIM
;
Kee Chun HONG
;
Yoon Seok HEO
;
Keon Young LEE
;
Sei Joong KIM
;
Young Up CHO
;
Seung Ik AHN
Author Information
1. Department of Surgery, Inha University School of Medicine, Incheon, Korea. inhags@gmail.com
- Publication Type:Original Article
- Keywords:
Peripheral arterial occlusive disease;
Arterial bypass;
Endovascular treatment;
Atherosclerosis;
Angioplasty
- MeSH:
Angioplasty;
Arterial Occlusive Diseases;
Atherosclerosis;
Consensus;
Critical Illness;
Humans;
Korea;
Physician's Practice Patterns;
Prospective Studies;
Retrospective Studies;
Western World
- From:Journal of the Korean Society for Vascular Surgery
2011;27(1):23-26
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Endovascular treatment for peripheral arterial obstructive disease (PAOD) is replacing traditional arterial bypass in the western world. Yet there are few reports to evaluate the pattern of clinical practice pattern for PAOD in Korea. This study was conducted to evaluate the treatment pattern for PAOD between endovascular treatment and arterial bypass, and to compare their clinical characteristics. METHODS: We conducted a retrospective study on the prospectively maintained database of patients who underwent endovascular treatment and arterial bypass for PAOD from March 2005 to December 2009 in Inha University Hospital. The aortoiliac lesions and femoropopliteal lesions were categorized by the Trans Atlantic Inter-Society Consensus (TASC) II classifications. Their treatments and clinical characteristics were compared between the former period (2005~2007 y) and the latter period (2008~2009 y). RESULTS: Three hundred nine cases (178 patients) were treated for PAOD by either arterial bypass or endovascular treatment. The patients' mean age was 69.1+/-11.3 year old. There was no difference in clinical characteristics between the two periods except for age. Endovascular treatments of both aortoiliac and femoropopliteal arterial lesions were increased in the latter period (P=0.023, P<0.001). Also, the endovascular treatments were increased in the TASC C and D aortoiliac and femoropopliteal lesions in the latter period (P=0.020, P<0.001). CONCLUSION: Endovascular treatment for PAOD is increasing in clinical practice and this shows feasibility in critically ill patient with TASC C and D lesions, although arterial bypass is still important.
